Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel Lewis acid catalyzed process for aromatic sulfinic acids reduces waste and energy. Reliable supply chain solution for pharmaceutical intermediate manufacturing partners.
Patent CN115353511A details a novel Pd-catalyzed multicomponent synthesis for carbonyl-bridged biheterocycles, offering cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN108659028B details a novel palladium-catalyzed trans-carboboration method for synthesizing high-purity fluorochemical intermediates with improved supply chain efficiency.
Patent CN112778261B details a mild silver-catalyzed route to isocoumarins, offering cost-effective manufacturing and scalable supply chain solutions.
Patent CN109384789B details a mild Ag(I)-catalyzed route to indoloazepines, offering cost-effective manufacturing for pharmaceutical intermediates.
Patent CN119330863A reveals air-stable synthesis reducing heavy metal use. Enables cost reduction in pharmaceutical intermediates manufacturing with high purity standards.
Patent CN115353511A details a novel multi-component synthesis of carbonyl-bridged biheterocycles, offering cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN101735095A details a novel copper-catalyzed oxidative coupling for alpha-carbonyl amides, offering significant cost reduction and simplified supply chains for pharmaceutical intermediate manufacturing.
Novel DMF-mediated synthesis of trifluoromethyl triazoles via patent CN114920707B. High efficiency, air-stable conditions ideal for API intermediates.
Patent CN111423381B reveals a mild palladium-catalyzed route for 2-trifluoromethyl imidazoles, offering cost reduction in API manufacturing and reliable supply chain solutions.
Novel radical cyclization method for benzimidazol[2,1-a]isoquinolin-6(5H)-ones. Efficient route reducing costs in pharmaceutical intermediate manufacturing with high purity.
Patent CN115286553B reveals nickel-catalyzed indole synthesis offering substantial cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN114195726B reveals robust CuCl catalyzed route for high-purity pharmaceutical intermediates. Achieve substantial cost reduction and supply chain reliability.
Novel Pd-catalyzed carbonylation method for 1,2,4-triazole-3-ones offers high yields and broad substrate scope for reliable pharmaceutical intermediate supply chains.
Patent CN111533706A reveals a copper-catalyzed one-pot method for triazines. Achieve cost reduction in fine chemical manufacturing with air-stable catalysts and high atom economy.
Novel one-step carbonylation cyclization for N-acyl indoles. High efficiency, broad substrate scope, cost-effective API intermediate manufacturing.
Patent CN113121462B reveals a safe, metal-free synthesis for 5-trifluoromethyl-1,2,3-triazoles using diazo compounds, offering significant cost and safety advantages.
Novel chiral phosphoric acid catalyzed resolution method for high-purity axially chiral oxindole-substituted styrenes, offering scalable synthesis for pharmaceutical intermediates.
Novel Mo/Cu co-catalyzed method for high-purity triazoles. Reduces steps and improves yield for pharmaceutical manufacturing.
Novel palladium-catalyzed reductive aminocarbonylation method for high-purity quinolinone derivatives, offering scalable routes for pharmaceutical intermediates.